Drug Discovery Informatics Market Size, Global Trends, Forecast to 2031

Table Of Content

Executive Summary

Research Scope & Segmentation

Research Objectives
Limitations & Assumptions
Market Scope & Segmentation
Currency & Pricing Considered

Market Opportunity Assessment

Emerging Regions / Countries
Emerging Companies
Emerging Applications / End Use

Market Trends

Drivers
Market Warning Factors
Latest Macro Economic Indicators
Geopolitical Impact
Technology Factors

Market Assessment

Porters Five Forces Analysis
Value Chain Analysis

Regulatory Framework

North America
Europe
APAC
Middle East and Africa
LATAM

ESG Trends

Global Drug Discovery Informatics Market Size Analysis

Global Drug Discovery Informatics Market Introduction
By Workflow
1. Introduction
  1. Workflow By Value
2. Drug Discovery Informatics
  1. By Value
  2. Identification and Validation Informatics
    1. Identification and Validation Informatics By Value
  3. Assay Development Informatics
    1. Assay Development Informatics By Value
  4. Lead Generation Informatics
    1. Lead Generation Informatics By Value
Development Informatics
1. Introduction
  1. Development Informatics By Value
2. Lead Optimization
  1. By Value
3. FHD Preparation
  1. By Value
4. Phase IA Informatics
  1. By Value
5. Phase IB/2 Informatics
  1. By Value
By Mode
1. Introduction
  1. Mode By Value
2. Outsourced Informatics
  1. By Value
3. In-house Informatics
  1. By Value
By Service
1. Introduction
  1. Service By Value
2. Sequence Analysis Platforms
  1. By Value
3. Molecular Modeling
  1. By Value
4. Docking
  1. By Value
5. Clinical trial data management
  1. By Value
6. Others
  1. By Value

North America Market Analysis

Introduction
By Workflow
1. Introduction
  1. Workflow By Value
2. Drug Discovery Informatics
  1. By Value
  2. Identification and Validation Informatics
    1. Identification and Validation Informatics By Value
  3. Assay Development Informatics
    1. Assay Development Informatics By Value
  4. Lead Generation Informatics
    1. Lead Generation Informatics By Value
Development Informatics
1. Introduction
  1. Development Informatics By Value
2. Lead Optimization
  1. By Value
3. FHD Preparation
  1. By Value
4. Phase IA Informatics
  1. By Value
5. Phase IB/2 Informatics
  1. By Value
By Mode
1. Introduction
  1. Mode By Value
2. Outsourced Informatics
  1. By Value
3. In-house Informatics
  1. By Value
By Service
1. Introduction
  1. Service By Value
2. Sequence Analysis Platforms
  1. By Value
3. Molecular Modeling
  1. By Value
4. Docking
  1. By Value
5. Clinical trial data management
  1. By Value
6. Others
  1. By Value
U.S.
1. By Workflow
  1. Introduction
    1. Workflow By Value
  2. Drug Discovery Informatics
    1. By Value
    2. Identification and Validation Informatics
      1. Identification and Validation Informatics By Value
    3. Assay Development Informatics
      1. Assay Development Informatics By Value
    4. Lead Generation Informatics
      1. Lead Generation Informatics By Value
2. Development Informatics
  1. Introduction
    1. Development Informatics By Value
  2. Lead Optimization
    1. By Value
  3. FHD Preparation
    1. By Value
  4. Phase IA Informatics
    1. By Value
  5. Phase IB/2 Informatics
    1. By Value
3. By Mode
  1. Introduction
    1. Mode By Value
  2. Outsourced Informatics
    1. By Value
  3. In-house Informatics
    1. By Value
4. By Service
  1. Introduction
    1. Service By Value
  2. Sequence Analysis Platforms
    1. By Value
  3. Molecular Modeling
    1. By Value
  4. Docking
    1. By Value
  5. Clinical trial data management
    1. By Value
  6. Others
    1. By Value
Canada

Europe Market Analysis

Introduction
By Workflow
1. Introduction
  1. Workflow By Value
2. Drug Discovery Informatics
  1. By Value
  2. Identification and Validation Informatics
    1. Identification and Validation Informatics By Value
  3. Assay Development Informatics
    1. Assay Development Informatics By Value
  4. Lead Generation Informatics
    1. Lead Generation Informatics By Value
Development Informatics
1. Introduction
  1. Development Informatics By Value
2. Lead Optimization
  1. By Value
3. FHD Preparation
  1. By Value
4. Phase IA Informatics
  1. By Value
5. Phase IB/2 Informatics
  1. By Value
By Mode
1. Introduction
  1. Mode By Value
2. Outsourced Informatics
  1. By Value
3. In-house Informatics
  1. By Value
By Service
1. Introduction
  1. Service By Value
2. Sequence Analysis Platforms
  1. By Value
3. Molecular Modeling
  1. By Value
4. Docking
  1. By Value
5. Clinical trial data management
  1. By Value
6. Others
  1. By Value
U.K.
1. By Workflow
  1. Introduction
    1. Workflow By Value
  2. Drug Discovery Informatics
    1. By Value
    2. Identification and Validation Informatics
      1. Identification and Validation Informatics By Value
    3. Assay Development Informatics
      1. Assay Development Informatics By Value
    4. Lead Generation Informatics
      1. Lead Generation Informatics By Value
2. Development Informatics
  1. Introduction
    1. Development Informatics By Value
  2. Lead Optimization
    1. By Value
  3. FHD Preparation
    1. By Value
  4. Phase IA Informatics
    1. By Value
  5. Phase IB/2 Informatics
    1. By Value
3. By Mode
  1. Introduction
    1. Mode By Value
  2. Outsourced Informatics
    1. By Value
  3. In-house Informatics
    1. By Value
4. By Service
  1. Introduction
    1. Service By Value
  2. Sequence Analysis Platforms
    1. By Value
  3. Molecular Modeling
    1. By Value
  4. Docking
    1. By Value
  5. Clinical trial data management
    1. By Value
  6. Others
    1. By Value
Germany
France
Spain
Italy
Russia
Nordic
Benelux
Rest of Europe

APAC Market Analysis

Introduction
By Workflow
1. Introduction
  1. Workflow By Value
2. Drug Discovery Informatics
  1. By Value
  2. Identification and Validation Informatics
    1. Identification and Validation Informatics By Value
  3. Assay Development Informatics
    1. Assay Development Informatics By Value
  4. Lead Generation Informatics
    1. Lead Generation Informatics By Value
Development Informatics
1. Introduction
  1. Development Informatics By Value
2. Lead Optimization
  1. By Value
3. FHD Preparation
  1. By Value
4. Phase IA Informatics
  1. By Value
5. Phase IB/2 Informatics
  1. By Value
By Mode
1. Introduction
  1. Mode By Value
2. Outsourced Informatics
  1. By Value
3. In-house Informatics
  1. By Value
By Service
1. Introduction
  1. Service By Value
2. Sequence Analysis Platforms
  1. By Value
3. Molecular Modeling
  1. By Value
4. Docking
  1. By Value
5. Clinical trial data management
  1. By Value
6. Others
  1. By Value
China
1. By Workflow
  1. Introduction
    1. Workflow By Value
  2. Drug Discovery Informatics
    1. By Value
    2. Identification and Validation Informatics
      1. Identification and Validation Informatics By Value
    3. Assay Development Informatics
      1. Assay Development Informatics By Value
    4. Lead Generation Informatics
      1. Lead Generation Informatics By Value
2. Development Informatics
  1. Introduction
    1. Development Informatics By Value
  2. Lead Optimization
    1. By Value
  3. FHD Preparation
    1. By Value
  4. Phase IA Informatics
    1. By Value
  5. Phase IB/2 Informatics
    1. By Value
3. By Mode
  1. Introduction
    1. Mode By Value
  2. Outsourced Informatics
    1. By Value
  3. In-house Informatics
    1. By Value
4. By Service
  1. Introduction
    1. Service By Value
  2. Sequence Analysis Platforms
    1. By Value
  3. Molecular Modeling
    1. By Value
  4. Docking
    1. By Value
  5. Clinical trial data management
    1. By Value
  6. Others
    1. By Value
Korea
Japan
India
Australia
Singapore
Taiwan
South East Asia
Rest of Asia-Pacific

Middle East and Africa Market Analysis

Introduction
By Workflow
1. Introduction
  1. Workflow By Value
2. Drug Discovery Informatics
  1. By Value
  2. Identification and Validation Informatics
    1. Identification and Validation Informatics By Value
  3. Assay Development Informatics
    1. Assay Development Informatics By Value
  4. Lead Generation Informatics
    1. Lead Generation Informatics By Value
Development Informatics
1. Introduction
  1. Development Informatics By Value
2. Lead Optimization
  1. By Value
3. FHD Preparation
  1. By Value
4. Phase IA Informatics
  1. By Value
5. Phase IB/2 Informatics
  1. By Value
By Mode
1. Introduction
  1. Mode By Value
2. Outsourced Informatics
  1. By Value
3. In-house Informatics
  1. By Value
By Service
1. Introduction
  1. Service By Value
2. Sequence Analysis Platforms
  1. By Value
3. Molecular Modeling
  1. By Value
4. Docking
  1. By Value
5. Clinical trial data management
  1. By Value
6. Others
  1. By Value
UAE
1. By Workflow
  1. Introduction
    1. Workflow By Value
  2. Drug Discovery Informatics
    1. By Value
    2. Identification and Validation Informatics
      1. Identification and Validation Informatics By Value
    3. Assay Development Informatics
      1. Assay Development Informatics By Value
    4. Lead Generation Informatics
      1. Lead Generation Informatics By Value
2. Development Informatics
  1. Introduction
    1. Development Informatics By Value
  2. Lead Optimization
    1. By Value
  3. FHD Preparation
    1. By Value
  4. Phase IA Informatics
    1. By Value
  5. Phase IB/2 Informatics
    1. By Value
3. By Mode
  1. Introduction
    1. Mode By Value
  2. Outsourced Informatics
    1. By Value
  3. In-house Informatics
    1. By Value
4. By Service
  1. Introduction
    1. Service By Value
  2. Sequence Analysis Platforms
    1. By Value
  3. Molecular Modeling
    1. By Value
  4. Docking
    1. By Value
  5. Clinical trial data management
    1. By Value
  6. Others
    1. By Value
Turkey
Saudi Arabia
South Africa
Egypt
Nigeria
Rest of MEA

LATAM Market Analysis

Introduction
By Workflow
1. Introduction
  1. Workflow By Value
2. Drug Discovery Informatics
  1. By Value
  2. Identification and Validation Informatics
    1. Identification and Validation Informatics By Value
  3. Assay Development Informatics
    1. Assay Development Informatics By Value
  4. Lead Generation Informatics
    1. Lead Generation Informatics By Value
Development Informatics
1. Introduction
  1. Development Informatics By Value
2. Lead Optimization
  1. By Value
3. FHD Preparation
  1. By Value
4. Phase IA Informatics
  1. By Value
5. Phase IB/2 Informatics
  1. By Value
By Mode
1. Introduction
  1. Mode By Value
2. Outsourced Informatics
  1. By Value
3. In-house Informatics
  1. By Value
By Service
1. Introduction
  1. Service By Value
2. Sequence Analysis Platforms
  1. By Value
3. Molecular Modeling
  1. By Value
4. Docking
  1. By Value
5. Clinical trial data management
  1. By Value
6. Others
  1. By Value
Brazil
1. By Workflow
  1. Introduction
    1. Workflow By Value
  2. Drug Discovery Informatics
    1. By Value
    2. Identification and Validation Informatics
      1. Identification and Validation Informatics By Value
    3. Assay Development Informatics
      1. Assay Development Informatics By Value
    4. Lead Generation Informatics
      1. Lead Generation Informatics By Value
2. Development Informatics
  1. Introduction
    1. Development Informatics By Value
  2. Lead Optimization
    1. By Value
  3. FHD Preparation
    1. By Value
  4. Phase IA Informatics
    1. By Value
  5. Phase IB/2 Informatics
    1. By Value
3. By Mode
  1. Introduction
    1. Mode By Value
  2. Outsourced Informatics
    1. By Value
  3. In-house Informatics
    1. By Value
4. By Service
  1. Introduction
    1. Service By Value
  2. Sequence Analysis Platforms
    1. By Value
  3. Molecular Modeling
    1. By Value
  4. Docking
    1. By Value
  5. Clinical trial data management
    1. By Value
  6. Others
    1. By Value
Mexico
Argentina
Chile
Colombia
Rest of LATAM

Competitive Landscape

Drug Discovery Informatics Market Share By Players
M&A Agreements & Collaboration Analysis

Market Players Assessment

PerkinElmer Inc.
1. Overview
2. Business Information
3. Revenue
4. ASP
5. SWOT Analysis
6. Recent Developments
Thermo Fisher Scientific Inc.
Certara
Novo Informatics Pvt. Ltd.
Collaborative Drug Discovery Inc.
Jubilant Life Sciences Limited
Selvita
Charles River Laboratories International Inc.
Cambridge Corporation
Albany Molecular Research, Inc.
GVK Biosciences Private Limited
Infosys Ltd.
Accenture
Oracle
Agilent Technologies Inc.

Research Methodology

Research Data
1. Secondary Data
  1. Major secondary sources
  2. Key data from secondary sources
2. Primary Data
  1. Key data from primary sources
  2. Breakdown of primaries
3. Secondary And Primary Research
  1. Key industry insights
Market Size Estimation
1. Bottom-Up Approach
2. Top-Down Approach
3. Market Projection
Research Assumptions
1. Assumptions
Limitations
Risk Assessment